Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Clinical and healthcare burden of myotonic dystrophy type 1 (DM1) in the United States: a claims-based study.
Journal: Journal of medical economics
Published: February 28, 2026
Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.
Journal: Neurology
Published: February 26, 2026
Test-Retest Reliability of Remote Assessments in Patients With Myotonic Dystrophy Type 1.
Journal: Neurology
Published: February 25, 2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.
Journal: The New England journal of medicine
Published: February 18, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.
Journal: Journal of neuromuscular diseases
Published: February 06, 2026
Fibro-adipogenic progenitors enhance functional and structural properties of human 3D tissue engineered skeletal muscles.
Journal: Journal of tissue engineering
Published: January 13, 2026
Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.
Journal: Muscle & nerve
Published: December 05, 2025
A pilot study using actigraphy to examine activity performance and its relationship with activity capacity in adults with facioscapulohumeral muscular dystrophy.
Journal: Journal of neuromuscular diseases
Published: October 21, 2025
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.
Journal: PloS one
Published: September 11, 2025
Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.
Journal: Neurology. Genetics
Published: November 26, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Journal: The Lancet. Neurology
Published: July 19, 2023
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
Journal: Brain : a journal of neurology
Published: January 23, 2023
Last Updated: 09/26/2026